Frederick Schnell named to new post of COA medical director

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Frederick Schnell was named medical director of the Community Oncology Alliance.

In this newly created position, Schnell will focus on issues related to oncology payment reform.

Schnell was a practicing community oncologist for 34 years, most recently as CEO, at Central Georgia Cancer Care in Macon, GA. He is a clinical assistant professor, Department of Medicine, Mercer University School of Medicine, Macon, GA. and a clinical assistant professor of hematology and oncology at the Winship Cancer Institute, Emory University School of Medicine.

Schnell has been the recipient of the Distinguished Cancer Clinician Award from the Georgia Cancer Coalition. He was a founding physician of COA, and has served as the third COA president, and as a member of the COA Board of Directors for many years.

“This is a crucial time for community oncology,” Schnell said in a statement. “There are obstacles and issues, to be sure, but the future is so much more positive and COA has more resources than at any time in its history.”

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
In January, FDA released a draft guidance entitled “Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval.” This release came roughly 20 months after the Oncologic Drugs Advisory Committee (ODAC) voted unanimously that minimal residual disease (MRD) negativity, in combination with complete response (CR), is an acceptable primary endpoint to support accelerated approval for multiple myeloma (MM) therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login